5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | SELL | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 5.69▼ | 5.66▲ | 5.66▲ | 5.98▼ | 6.28▼ |
MA10 | 5.66▲ | 5.67▼ | 5.70▼ | 6.19▼ | 6.22▼ |
MA20 | 5.66▲ | 5.82▼ | 5.92▼ | 6.35▼ | 6.02▼ |
MA50 | 5.86▼ | 6.09▼ | 6.15▼ | 6.22▼ | 6.25▼ |
MA100 | 6.08▼ | 6.26▼ | 6.32▼ | 6.03▼ | 6.71▼ |
MA200 | 6.25▼ | 6.24▼ | 6.23▼ | 6.07▼ | N/A |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.019▲ | 0.005▲ | -0.014▼ | -0.104▼ | 0.005▲ |
RSI | 44.923▼ | 39.968▼ | 38.595▼ | 37.316▼ | 44.959▼ |
STOCH | 75.660 | 52.636 | 27.867 | 24.021 | 47.716 |
WILL %R | -34.545 | -56.627 | -73.529 | -87.050▼ | -81.500▼ |
CCI | 47.252 | -28.455 | -51.361 | -199.808▼ | -99.920 |
Tuesday, September 16, 2025 05:20 AM
Coya Therapeutics, Inc. (NASDAQ: COYA) ("Coya" or the "Company"), a clinical-stage biotechnology company developing biologics intended to enhance regulatory T cell (Treg) function, today announced ...
|
Tuesday, September 16, 2025 04:55 AM
Coya Therapeutics Inc. (NASDAQ:COYA) on Tuesday announced results from a study designed to evaluate the effects of COYA 303 (LD IL-2 and GLP-1RA), Coya's investigational biologic combination, in an in ...
|
Thursday, September 04, 2025 05:14 AM
Coya Therapeutics, Inc. (NASDAQ: COYA) ("Coya" or the "Company"), a clinical-stage biotechnology company focused on developing biologics that enhance regulatory T cell (Treg) function in patients with ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
16/09/25 | 5.49 | 5.765 | 5.49 | 5.67 | 154,370 |
15/09/25 | 6.06 | 6.184 | 5.621 | 5.68 | 131,554 |
12/09/25 | 6.25 | 6.423 | 5.78 | 6.05 | 190,101 |
11/09/25 | 6.36 | 6.525 | 6.16 | 6.21 | 158,275 |
10/09/25 | 6.28 | 6.4311 | 6.16 | 6.31 | 39,529 |
09/09/25 | 6.42 | 6.4336 | 6.05 | 6.27 | 103,122 |
08/09/25 | 6.32 | 6.49 | 6.108 | 6.37 | 123,232 |
05/09/25 | 6.38 | 6.605 | 5.96 | 6.27 | 214,649 |
04/09/25 | 6.80 | 6.80 | 6.00 | 6.38 | 73,548 |
03/09/25 | 6.52 | 6.7993 | 6.51 | 6.69 | 44,791 |
|
|
||||
|
|
||||
|
|